Avanos Medical Inc (NYSE:AVNS)
$ 15.2 -0.2 (-1.3%) Market Cap: 698.55 Mil Enterprise Value: 811.75 Mil PE Ratio: 44.71 PB Ratio: 0.57 GF Score: 63/100

Avanos Medical Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript

Mar 22, 2022 / 01:45PM GMT
Release Date Price: $32.47 (+0.96%)
Matt Mishan
KeyBanc Capital Markets Inc. - Analyst

Hey, good morning, everyone. Welcome again to the first day of the KeyBanc Life Sciences and MedTech Investor Forum. My name is Matt Mishan, a senior medtech analyst. I'm pleased to be joined by Avanos, which is represented today by CEO, Joe Woody; and CFO, Michael Greiner. For the audience, I'll start us off, but questions can be submitted directly to me by typing into the box below the video screen, and I can then relay.

Questions & Answers

Matt Mishan
KeyBanc Capital Markets Inc. - Analyst

I guess guys first, just as an opening, thank you for joining. The current challenge, in my opinion, with the macro is that there's so many disconnected moving pieces with Russia inflation, China, and then the US recovery. Just to level set, what is most important for your business from a macro perspective, and where are you guys spending the most time at this point?

Joe Woody
Avanos Medical, Inc. - CEO

Thanks, Matt. We were pretty happy with our Q4 performance

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot